[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Lane et al., 1991 - Google Patents

LPS promotes CB3-induced myocarditis in resistant B10. A mice

Lane et al., 1991

View PDF
Document ID
13144826467964305245
Author
Lane J
Neumann D
Lafond-Walker A
Herskowitz A
Rose N
Publication year
Publication venue
Cellular immunology

External Links

Snippet

Abstract Coxsackie virus B3 (CB3) infection of A/J or A. SW mice results in autoimmune myocarditis characterized by a diffuse mononuclear cell infiltrate and heart-specific autoantibodies. C57BL/10 congenic mice that are identically treated are resistant to this …
Continue reading at www.sciencedirect.com (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants

Similar Documents

Publication Publication Date Title
Lane et al. LPS promotes CB3-induced myocarditis in resistant B10. A mice
Dickerson et al. Ichthyophthirius multifiliis: a model of cutaneous infection and immunity in fishes
Olsson et al. Bidirectional activating signals between Trypanosoma brucei and CD8+ T cells: a trypanosome‐released factor triggers interferon‐γ production that stimulates parasite growth
Dinarello Interleukin-18 and the pathogenesis of inflammatory diseases
Rizzo et al. IL-10 has a protective role in experimental autoimmune uveoretinitis.
Alyanakian et al. Transforming growth factor-β and natural killer T-cells are involved in the protective effect of a bacterial extract on type 1 diabetes
JP2002504334A (en) COMPOSITIONS COMPRISING OX-40 RECEPTOR BINDING FACTOR OR NUCLEIC ACID ENCODING THEREOF AND METHODS FOR ENHANCED ANTIGEN-SPECIFIC IMMune RESPONSE
Mattapallil et al. Interleukin 22 ameliorates neuropathology and protects from central nervous system autoimmunity
Wilson et al. Immune responses to the radiation-attenuated schistosome vaccine: what can we learn from knock-out mice?
CA2459348A1 (en) Antibodies to non-functional p2x7receptor, diagnosis and treatment of cancers and other conditions
Lasco et al. Evaluating the role of tumor necrosis factor-alpha in experimental pulmonary tuberculosis in the guinea pig
CN101137664A (en) Antigenic epitopes of interleukin-21, related antibodies and their use in medical field
Cordero et al. Alpha-1-acid glycoprotein, its local production and immunopathological participation in experimental pulmonary tuberculosis
CN112138146B (en) Application of MANF protein
US7790158B2 (en) Methods for epitope-specific and cytokine/anticytokine combination immunotherapies
Valbuena et al. Effect of blocking the CXCL9/10-CXCR3 chemokine system in the outcome of endothelial-target rickettsial infections
Riera et al. Experimental cryptococcosis in guinea pigs
EP1367393A1 (en) Methods for using the CD 163 pathway for modulating an immune response
Grau et al. Immune mechanisms in bacterial and parasitic diseases: protective immunity versus pathology
Fidel Jr et al. Regulation of granulomatous inflammation in murine schistosomiasis. V. Antigen-induced T cell-derived suppressor factors down-regulate proliferation and IL-2, but not IL-4, production by CD4+ effector T cells.
Anguita et al. B7-1 and B7-2 monoclonal antibodies modulate the severity of murine Lyme arthritis
Matsui et al. Adenovirus-mediated gene transfer of ICOSIg fusion protein ameliorates ongoing experimental autoimmune myocarditis
Yang et al. Dynamic analysis of T-lymphocyte function in relation to hepatopathologic changes and effect of interleukin-12 treatment in mice infected with Schistosoma japonicum
KR20040030948A (en) Use of il-18 inhibitors in hypersensitivity disorders
Zbar et al. Tumor rejection mediated by an amphotropic murine leukemia virus